The United States of America; as represented by the Secretary; Department of Health and Human Services
发明人:
Chatterjee, Deb K.,Kaczmarczyk, Stanislaw J.
申请号：
AU2014365777
公开号：
AU2014365777A1
申请日:
2014.12.16
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
Described herein is a method of preventing or treating a disease in a mammalian subject, comprising administering to the subject who is in need thereof an effective dosage of a pharmaceutical composition comprising a virus like particle (VLP) comprising: an alphavirus replicon comprising a recombinant polynucleotide, wherein the polynucleotide comprises a sequence encoding both subunits of a human class II major histocompatibility antigen, a retroviral gag protein, and a fusogenic envelope protein, wherein the VLP does not contain an alphavirus structural protein gene.
